Artículos

A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia / Hai Ning Yuan en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 264-370 Título : A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia Tipo de documento: texto impreso Autores: Hai Ning Yuan, Autor ; Chuan Yue Wang, Autor ; Cho Wing Sze, Autor Fecha de publicación: 2023 Artículo en la página: pp. 264-370 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Amenorrea, Antipsicóticos, Bromocriptina, Terapia con medicamentos, Hiperprolactinemia, Oligomenorrea, Fitoterapia, Progesterona, Risperidona, Esquizofrenia. Resumen: Hyperprolactinemia is a common adverse effect that occurs as a result of antipsychotic therapies, which often results in discontinuation. Empirical evidence has shown that some herbal medicines have suppressive effects on prolactin (PRL) hyperactivities. This study was designed to compare the herbal preparation called Peony-Glycyrrhiza Decoction (PGD) with bromocriptine (BMT), a dopamine agonist widely used for PRL-secreting disorders, in the treatment of risperidone-induced hyperprolactinemia. Link: ./index.php?lvl=notice_display&id=30846 [artículo] A randomized, crossover comparison of herbal medicine and bromocriptine against risperidone-induced hyperprolactinemia in patients with schizophrenia [texto impreso] / Hai Ning Yuan, Autor ; Chuan Yue Wang, Autor ; Cho Wing Sze, Autor . - 2023 . - pp. 264-370. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 264-370 Palabras clave: Amenorrea, Antipsicóticos, Bromocriptina, Terapia con medicamentos, Hiperprolactinemia, Oligomenorrea, Fitoterapia, Progesterona, Risperidona, Esquizofrenia. Resumen: Hyperprolactinemia is a common adverse effect that occurs as a result of antipsychotic therapies, which often results in discontinuation. Empirical evidence has shown that some herbal medicines have suppressive effects on prolactin (PRL) hyperactivities. This study was designed to compare the herbal preparation called Peony-Glycyrrhiza Decoction (PGD) with bromocriptine (BMT), a dopamine agonist widely used for PRL-secreting disorders, in the treatment of risperidone-induced hyperprolactinemia. Link: ./index.php?lvl=notice_display&id=30846

A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan / Susan Shur-Fen Gau en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 271-278 Título : A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan Tipo de documento: texto impreso Autores: Susan Shur-Fen Gau, Autor ; Ching Hu Chung, Autor ; Churn Shiouh Gau, Autor Fecha de publicación: 2023 Artículo en la página: pp. 271-278 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Costos de medicamentos, Terapia con medicamentos, Haloperidol, Duración de la estancia - economía, Cuidados a largo plazo - economía, Referencia y Consulta, Esquizofrenia - farmacoterapia. Resumen: The study prospectively examined the economic outcomes and comedications among first-episode schizophrenic patients treated with monotherapy of second-generation antipsychotic agents (SGAs) continuously as compared with each other and with haloperidol. The sample included 3047 out of Taiwan's national sample of 29,341 first-episode schizophrenic patients, who were selected, based on International Classification of Disease, Ninth Revision code 295, from the National Health Insurance original claims data from 1999 to 2004. Link: ./index.php?lvl=notice_display&id=30847 [artículo] A pharmacoeconomic analysis of atypical antipsychotics and haloperidol in first-episode schizophrenic patients in taiwan [texto impreso] / Susan Shur-Fen Gau, Autor ; Ching Hu Chung, Autor ; Churn Shiouh Gau, Autor . - 2023 . - pp. 271-278. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 271-278 Palabras clave: Antipsicóticos, Costos de medicamentos, Terapia con medicamentos, Haloperidol, Duración de la estancia - economía, Cuidados a largo plazo - economía, Referencia y Consulta, Esquizofrenia - farmacoterapia. Resumen: The study prospectively examined the economic outcomes and comedications among first-episode schizophrenic patients treated with monotherapy of second-generation antipsychotic agents (SGAs) continuously as compared with each other and with haloperidol. The sample included 3047 out of Taiwan's national sample of 29,341 first-episode schizophrenic patients, who were selected, based on International Classification of Disease, Ninth Revision code 295, from the National Health Insurance original claims data from 1999 to 2004. Link: ./index.php?lvl=notice_display&id=30847

Maternal use of antipsychotics in early pregnancy and delivery outcome en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 279-288 Título : Maternal use of antipsychotics in early pregnancy and delivery outcome Tipo de documento: texto impreso Fecha de publicación: 2023 Artículo en la página: pp. 279-288 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Anomalías inducidas por fármacos, Anticonvulsivos, Antipsicóticos, Cesáreas, Diabetes gestacional, Defectos cardíacos congénitos, Compuestos de Litio, Fenotiazinas, Embarazo - complicaciones, Embarazo Múltiple, Proclorperazina, Trastornos psicótico. Resumen: The effect of various antipsychotics during pregnancy has repeatedly been studied, but for most atypical antipsychotics, only little information is available. We identified from the Swedish Medical Birth Register 2908 women who had reported the use of any antipsychotic or lithium in early pregnancy and studied malformation rates with data also from the Register of Congenital Malformations and the Hospital Discharge Register. Link: ./index.php?lvl=notice_display&id=30848 [artículo] Maternal use of antipsychotics in early pregnancy and delivery outcome [texto impreso] . - 2023 . - pp. 279-288. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 279-288 Palabras clave: Anomalías inducidas por fármacos, Anticonvulsivos, Antipsicóticos, Cesáreas, Diabetes gestacional, Defectos cardíacos congénitos, Compuestos de Litio, Fenotiazinas, Embarazo - complicaciones, Embarazo Múltiple, Proclorperazina, Trastornos psicótico. Resumen: The effect of various antipsychotics during pregnancy has repeatedly been studied, but for most atypical antipsychotics, only little information is available. We identified from the Swedish Medical Birth Register 2908 women who had reported the use of any antipsychotic or lithium in early pregnancy and studied malformation rates with data also from the Register of Congenital Malformations and the Hospital Discharge Register. Link: ./index.php?lvl=notice_display&id=30848

Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment / Rocio Perez Iglesias en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 289-295 Título : Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment Tipo de documento: texto impreso Autores: Rocio Perez Iglesias, Autor ; Jose Luis Vázquez Barquero, Autor ; Jose Antonio Amado, Autor Fecha de publicación: 2023 Artículo en la página: pp. 289-295 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antipsicóticos, Benzodiacepinas, Composición corporal, Índice de masa corporal, Haloperidol, Insulina, Leptina, Nicotinamida, Trastornos psicóticos, Trastornos psicóticos, Esquizofrenia. Resumen: Weight gain has become one of the most common and concerning side effects of antipsychotic treatment. The mechanisms whereby antipsychotics induce weight gain are not known. It has been suggested that peptides related to food intake and energy balance could play a role in weight gain secondary to antipsychotic therapy. Link: ./index.php?lvl=notice_display&id=30849 [artículo] Effect of antipsychotics on peptides involved in energy balance in drug-naive psychotic patients after 1 year of treatment [texto impreso] / Rocio Perez Iglesias, Autor ; Jose Luis Vázquez Barquero, Autor ; Jose Antonio Amado, Autor . - 2023 . - pp. 289-295. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 289-295 Palabras clave: Antipsicóticos, Benzodiacepinas, Composición corporal, Índice de masa corporal, Haloperidol, Insulina, Leptina, Nicotinamida, Trastornos psicóticos, Trastornos psicóticos, Esquizofrenia. Resumen: Weight gain has become one of the most common and concerning side effects of antipsychotic treatment. The mechanisms whereby antipsychotics induce weight gain are not known. It has been suggested that peptides related to food intake and energy balance could play a role in weight gain secondary to antipsychotic therapy. Link: ./index.php?lvl=notice_display&id=30849

Methylphenidate for the treatment of apathy in alzheimer disease / Nathan Herrmann en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 296-301 Título : Methylphenidate for the treatment of apathy in alzheimer disease : Prediction of response using dextroamphetamine challenge Tipo de documento: texto impreso Autores: Nathan Herrmann, Autor ; Lana S. Rothenburg, Autor ; Sandra E. Black, Autor Fecha de publicación: 2023 Artículo en la página: pp. 296-301 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Enfermedad de Alzheimer, Efectos cerebrales, Estimulantes del Sistema Nervioso Central, Letargo - terapia farmacológica, Metilfenidato, Motivación, Pruebas neuropsicológicas. Resumen: Apathy is a common behavioral symptom of Alzheimer's disease (AD), being present in up to 70% of patients. Apathy in AD and non-AD populations has been associated with dysfunction in the dopaminergic brain reward system, suggesting that pharmacotherapeutic targeting of this system may be an effective treatment for apathy in AD. Link: ./index.php?lvl=notice_display&id=30850 [artículo] Methylphenidate for the treatment of apathy in alzheimer disease : Prediction of response using dextroamphetamine challenge [texto impreso] / Nathan Herrmann, Autor ; Lana S. Rothenburg, Autor ; Sandra E. Black, Autor . - 2023 . - pp. 296-301. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 296-301 Palabras clave: Enfermedad de Alzheimer, Efectos cerebrales, Estimulantes del Sistema Nervioso Central, Letargo - terapia farmacológica, Metilfenidato, Motivación, Pruebas neuropsicológicas. Resumen: Apathy is a common behavioral symptom of Alzheimer's disease (AD), being present in up to 70% of patients. Apathy in AD and non-AD populations has been associated with dysfunction in the dopaminergic brain reward system, suggesting that pharmacotherapeutic targeting of this system may be an effective treatment for apathy in AD. Link: ./index.php?lvl=notice_display&id=30850

A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension / Michael E. Thase en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 302-307 Título : A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension Tipo de documento: texto impreso Autores: Michael E. Thase, Autor ; Barbara R. Haight, Autor ; Marty C. Johnson, Autor Fecha de publicación: 2023 Artículo en la página: pp. 302-307 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Presión arterial, Frecuencia cardíaca, Hipertensión - inducida químicamente Resumen: The effects of bupropion on blood pressure and heart rate were evaluated in a double-blind, placebo-controlled study of community volunteers with untreated mild (stage 1) hypertension (systolic blood pressure [SBP], 140-159 mm Hg, and/or diastolic blood pressure, 90-99 mm Hg). Three hundred subjects were randomly assigned (1:1:1:1) to 4 weeks of placebo or bupropion sustained release (SR) 150, 300, or 400 mg/d. Link: ./index.php?lvl=notice_display&id=30851 [artículo] A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension [texto impreso] / Michael E. Thase, Autor ; Barbara R. Haight, Autor ; Marty C. Johnson, Autor . - 2023 . - pp. 302-307. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 302-307 Palabras clave: Antidepresivos, Presión arterial, Frecuencia cardíaca, Hipertensión - inducida químicamente Resumen: The effects of bupropion on blood pressure and heart rate were evaluated in a double-blind, placebo-controlled study of community volunteers with untreated mild (stage 1) hypertension (systolic blood pressure [SBP], 140-159 mm Hg, and/or diastolic blood pressure, 90-99 mm Hg). Three hundred subjects were randomly assigned (1:1:1:1) to 4 weeks of placebo or bupropion sustained release (SR) 150, 300, or 400 mg/d. Link: ./index.php?lvl=notice_display&id=30851

Tiagabine in adult patients with generalized anxiety disorder / Mark H. Pollack en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 308-316 Título : Tiagabine in adult patients with generalized anxiety disorder : Results from 3 randomized, double-blind, placebo-controlled, parallel-group studies Tipo de documento: texto impreso Autores: Mark H. Pollack, Autor ; Fang Xie, Autor ; Madhukar H. Trivedi, Autor Fecha de publicación: 2023 Artículo en la página: pp. 308-316 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Ansiolíticos, Trastornos de ansiedad, Ensayos Clínicos, Agonistas de GABA, Ácidos Nipecóticos. Resumen: The objective of these studies was to evaluate the efficacy and tolerability of tiagabine, a selective γ-aminobutyric acid reuptake inhibitor, in adult patients with generalized anxiety disorder (GAD). Patients with a diagnosis of GAD were enrolled in 1 of 3 randomized, placebo-controlled, 10-week studies. In each study, tiagabine was taken twice daily in divided doses-4, 8, or 12 mg/d in a fixed-dose study and 4-16 mg/d in two flexible-dose trials. Link: ./index.php?lvl=notice_display&id=30852 [artículo] Tiagabine in adult patients with generalized anxiety disorder : Results from 3 randomized, double-blind, placebo-controlled, parallel-group studies [texto impreso] / Mark H. Pollack, Autor ; Fang Xie, Autor ; Madhukar H. Trivedi, Autor . - 2023 . - pp. 308-316. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 308-316 Palabras clave: Ansiolíticos, Trastornos de ansiedad, Ensayos Clínicos, Agonistas de GABA, Ácidos Nipecóticos. Resumen: The objective of these studies was to evaluate the efficacy and tolerability of tiagabine, a selective γ-aminobutyric acid reuptake inhibitor, in adult patients with generalized anxiety disorder (GAD). Patients with a diagnosis of GAD were enrolled in 1 of 3 randomized, placebo-controlled, 10-week studies. In each study, tiagabine was taken twice daily in divided doses-4, 8, or 12 mg/d in a fixed-dose study and 4-16 mg/d in two flexible-dose trials. Link: ./index.php?lvl=notice_display&id=30852

Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence / Michael Soyka en Journal of Clinical Psychopharmacology, Año 2008 - Vol. 28 - No. 3 (Junio)

Público ISBD [artículo]  inJournal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 317-324 Título : Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence : Results from a placebo-controlled, double-blind trial Tipo de documento: texto impreso Autores: Michael Soyka, Autor ; Gabriele Koller, Autor ; Peggy Schmidt, Autor Fecha de publicación: 2023 Artículo en la página: pp. 317-324 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Alcoholismo, Índice de masa corporal, Piperidinas, Pirazoles. Resumen: Multiple lines of evidence suggest that the endocannabinoid system is implicated in the development of alcohol dependence. In addition, in animal models, the cannabinoid receptor 1 blocker rimonabant was found to decrease alcohol consumption, possibly by indirect modulation of dopaminergic neurotransmission. Link: ./index.php?lvl=notice_display&id=30853 [artículo] Cannabinoid receptor 1 blocker rimonabant (sr 141716) for treatment of alcohol dependence : Results from a placebo-controlled, double-blind trial [texto impreso] / Michael Soyka, Autor ; Gabriele Koller, Autor ; Peggy Schmidt, Autor . - 2023 . - pp. 317-324. Idioma : Inglés (eng) Idioma original : Inglés (eng) in Journal of Clinical Psychopharmacology > Año 2008 - Vol. 28 - No. 3 (Junio) . - pp. 317-324 Palabras clave: Alcoholismo, Índice de masa corporal, Piperidinas, Pirazoles. Resumen: Multiple lines of evidence suggest that the endocannabinoid system is implicated in the development of alcohol dependence. In addition, in animal models, the cannabinoid receptor 1 blocker rimonabant was found to decrease alcohol consumption, possibly by indirect modulation of dopaminergic neurotransmission. Link: ./index.php?lvl=notice_display&id=30853